Anders Helldén

642 total citations
23 papers, 417 citations indexed

About

Anders Helldén is a scholar working on Epidemiology, Pediatrics, Perinatology and Child Health and Pharmacology. According to data from OpenAlex, Anders Helldén has authored 23 papers receiving a total of 417 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Epidemiology, 5 papers in Pediatrics, Perinatology and Child Health and 5 papers in Pharmacology. Recurrent topics in Anders Helldén's work include Herpesvirus Infections and Treatments (7 papers), Cytomegalovirus and herpesvirus research (6 papers) and Pharmacogenetics and Drug Metabolism (4 papers). Anders Helldén is often cited by papers focused on Herpesvirus Infections and Treatments (7 papers), Cytomegalovirus and herpesvirus research (6 papers) and Pharmacogenetics and Drug Metabolism (4 papers). Anders Helldén collaborates with scholars based in Sweden, Malaysia and Canada. Anders Helldén's co-authors include Ingegerd Odar‐Cederlöf, Ulf Bergman, Lars Ståhle, Jan‐Olof Svensson, Gunnar Öhlén, Mia von Euler, Jan Lycke, Juliette Säwe, Charlotte Medin and Lisbeth Barkholt and has published in prestigious journals such as Journal of Antimicrobial Chemotherapy, Journal of the Neurological Sciences and Nephrology Dialysis Transplantation.

In The Last Decade

Anders Helldén

22 papers receiving 402 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Anders Helldén Sweden 11 159 67 62 56 47 23 417
Stephanie D. Schech United States 8 86 0.5× 33 0.5× 31 0.5× 60 1.1× 63 1.3× 12 469
Mohammed Danjuma Qatar 13 76 0.5× 37 0.6× 143 2.3× 79 1.4× 35 0.7× 64 561
Molouk Hadjibabaie Iran 11 61 0.4× 71 1.1× 39 0.6× 26 0.5× 38 0.8× 32 414
Sanjay D’Cruz India 15 76 0.5× 88 1.3× 82 1.3× 43 0.8× 26 0.6× 63 650
Eric M. Tichy United States 14 117 0.7× 87 1.3× 45 0.7× 25 0.4× 175 3.7× 40 615
N. Partovi Canada 9 161 1.0× 49 0.7× 82 1.3× 12 0.2× 44 0.9× 15 356
Marion Lepelley France 16 61 0.4× 52 0.8× 75 1.2× 33 0.6× 55 1.2× 42 574
Yaa‐Hui Dong Taiwan 14 121 0.8× 37 0.6× 22 0.4× 111 2.0× 27 0.6× 35 792
Andreea Farcaș Romania 11 51 0.3× 143 2.1× 44 0.7× 61 1.1× 84 1.8× 41 549
A. Scott Mathis United States 14 116 0.7× 26 0.4× 85 1.4× 76 1.4× 31 0.7× 41 537

Countries citing papers authored by Anders Helldén

Since Specialization
Citations

This map shows the geographic impact of Anders Helldén's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anders Helldén with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anders Helldén more than expected).

Fields of papers citing papers by Anders Helldén

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anders Helldén. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anders Helldén. The network helps show where Anders Helldén may publish in the future.

Co-authorship network of co-authors of Anders Helldén

This figure shows the co-authorship network connecting the top 25 collaborators of Anders Helldén. A scholar is included among the top collaborators of Anders Helldén based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anders Helldén. Anders Helldén is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Helldén, Anders, et al.. (2022). Rapid determination of acyclovir, its main metabolite 9‐carboxymethoxymethylguanine, ganciclovir, and penciclovir in human serum using LC–MS/MS. Biomedical Chromatography. 36(4). e5315–e5315. 13 indexed citations
3.
Helldén, Anders, Åse Östholm Balkhed, Mats Haglund, et al.. (2021). Case Report: Subtherapeutic Vancomycin and Meropenem Concentrations due to Augmented Renal Clearance in a Patient With Intracranial Infection Caused by Streptococcus intermedius. Frontiers in Pharmacology. 12. 728075–728075. 10 indexed citations
4.
Helldén, Anders, Ulf Bergman, & Ingegerd Odar‐Cederlöf. (2019). The importance of correct estimation of renal function for drug treatment in hospitalized elderly patients, especially women: A prospective observational study. Clinical Nephrology. 91(4). 254–264. 7 indexed citations
5.
Helldén, Anders, et al.. (2015). Development of a computerised decisions support system for renal risk drugs targeting primary healthcare. BMJ Open. 5(7). e006775–e006775. 9 indexed citations
6.
Kılıç, Levent, Ali Akdoğan, Melih O. Babaoğlu, et al.. (2015). Lower CYP2C9 activity in Turkish patients with Behçet’s disease compared to healthy subjects: a down-regulation due to inflammation?. European Journal of Clinical Pharmacology. 71(10). 1223–1228. 10 indexed citations
7.
Peredo, Inti, Anders Helldén, Anton Pohanka, et al.. (2015). Ganciclovir concentrations in the cerebral extracellular space after valganciclovir treatment; a case study. BMJ Case Reports. 2015. bcr2014207694–bcr2014207694. 9 indexed citations
8.
Nulman, Irena, et al.. (2014). Implications of serum creatinine measurements on GFR estimation and vancomycin dosing in children. The Journal of Clinical Pharmacology. 54(7). 785–791. 5 indexed citations
9.
Helldén, Anders, Ingegerd Odar‐Cederlöf, Göran Nilsson, et al.. (2013). Renal function estimations and dose recommendations for dabigatran, gabapentin and valaciclovir: a data simulation study focused on the elderly. BMJ Open. 3(4). e002686–e002686. 32 indexed citations
10.
Euler, Mia von, et al.. (2013). Differential Diagnosis of Central Nervous System Involvement in a Patient Treated With Acyclovir. Therapeutic Drug Monitoring. 35(4). 417–419. 5 indexed citations
11.
Lindén, Thomas & Anders Helldén. (2013). Cotard's syndrome as an adverse effect of acyclovir treatment in renal failure. Journal of the Neurological Sciences. 333. e650–e650. 1 indexed citations
12.
Helldén, Anders & Parvaz Madadi. (2013). Pregnancy and Pharmacogenomics in the Context of Drug Metabolism and Response. Pharmacogenomics. 14(14). 1779–1791. 10 indexed citations
13.
Helldén, Anders, Georgios Panagiotidis, Petter Johansson, et al.. (2012). The dopaminergic stabilizer pridopidine is to a major extent N-depropylated by CYP2D6 in humans. European Journal of Clinical Pharmacology. 68(9). 1281–1286. 3 indexed citations
14.
Teh, Lay Kek, Anders Helldén, Karin Hellgren, et al.. (2012). Search for the molecular basis of ultra-rapid CYP2C9-catalysed metabolism: relationship between SNP IVS8-109A>T and the losartan metabolism phenotype in Swedes. European Journal of Clinical Pharmacology. 68(7). 1033–1042. 13 indexed citations
15.
Helldén, Anders, Ulf Bergman, Karin Hellgren, et al.. (2010). Fluconazole-induced intoxication with phenytoin in a patient with ultra-high activity of CYP2C9. European Journal of Clinical Pharmacology. 66(8). 791–795. 9 indexed citations
16.
Helldén, Anders, et al.. (2009). Adverse Drug Reactions and Impaired Renal Function in Elderly Patients Admitted to the Emergency Department. Drugs & Aging. 26(7). 595–606. 65 indexed citations
17.
Liljeqvist, Sissela, et al.. (2008). Pulmonary embolism associated with the use of anabolic steroids. European Journal of Internal Medicine. 19(3). 214–215. 36 indexed citations
18.
Helldén, Anders, et al.. (2007). Death delusion. BMJ. 335(7633). 1305–1305. 11 indexed citations
19.
Helldén, Anders, Jan Lycke, Tatiana Vander, et al.. (2006). The aciclovir metabolite CMMG is detectable in the CSF of subjects with neuropsychiatric symptoms during aciclovir and valaciclovir treatment. Journal of Antimicrobial Chemotherapy. 57(5). 945–949. 55 indexed citations
20.
Helldén, Anders, Ingegerd Odar‐Cederlöf, Lisbeth Barkholt, et al.. (2003). High serum concentrations of the acyclovir main metabolite 9-carboxymethoxymethylguanine in renal failure patients with acyclovir-related neuropsychiatric side effects: an observational study. Nephrology Dialysis Transplantation. 18(6). 1135–1141. 76 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Stephanie D. Schech Breakdown of academic impact, for papers by Mohammed Danjuma Breakdown of academic impact, for papers by Molouk Hadjibabaie Breakdown of academic impact, for papers by Sanjay D’Cruz Breakdown of academic impact, for papers by Eric M. Tichy Breakdown of academic impact, for papers by N. Partovi Breakdown of academic impact, for papers by Marion Lepelley Breakdown of academic impact, for papers by Yaa‐Hui Dong Breakdown of academic impact, for papers by Andreea Farcaș Breakdown of academic impact, for papers by A. Scott Mathis
Rankless by CCL
2026